Novartis data at 2019 ASH and SABCS underscore our evolving R&D approach in innovative platforms to reimagine medicine and help improve patient outcomes.

Results of the Sickle Cell World Assessment Survey (SWAY) highlight the impact this debilitating disease has on patients and their families.

Fourteen weeks. That’s how many weeks all new Novartis parents will get as minimum paid parental leave, regardless of gender, rolling out from July 1, 2019.

Novartis and other industry leaders call for action to address antimicrobial resistance, one of the world’s most serious public health challenges

RAND Corporation and the Moran Company issued reports discussing the cost savings associated with biosimilars.

Individualized CAR‑T therapy uses a patient’s own immune system to fight certain types of cancers.